x

Posted 18 July, 2023

INTERNATIONAL ISOTOPES INC appointed Shahe Bagderjian as new CEO

OTC:INIS appointed new Chief Executive Officer Shahe Bagderjian in a 8-K filed on 18 July, 2023.


  In addition, on July 12, 2023, Shahe Bagderjian, President of the Company, was appointed to replace Mr. Laflin as Chief Executive Officer, effective September 1, 2023.  

Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of INTERNATIONAL ISOTOPES INC
Health Care/Life Sciences • Pharmaceuticals
International Isotopes, Inc. engages in the manufacture of nuclear medicine calibration and reference standards cobalt tele therapy sources, as well as radioisotopes and radiochemical for medical research and clinical devices. It operates through the following segments: Radiochemical Products, Cobalt Products, Nuclear Medicine Standards, Fluorine Products, and Radiological Services. The Radiochemical Products segment includes production and distribution of various isotopically pure radio chemicals for medical, industrial, or research applications. The Cobalt Products segment includes management of a cobalt irradiation contract, fabrication of cobalt capsules for tele therapy or irradiation devices, and recycling of expended cobalt sources. The Nuclear Medicine Standards segment consists of the manufacture of sources and standards associated with Single Photon Emission Computed Tomography imaging, patient positioning, and calibration or operational testing of dose measuring equipment for the nuclear pharmacy industry. The Fluorine Products segment is involved in the production of small-scale qualification samples of high purity fluoride gas for various industrial applications. The Radiological Services Segment concerns a wide array of miscellaneous services that consists of gemstone processing and field services that include source installation, removal, and radiation device decommissioning. The company was founded in November 1995 and is headquartered in Idaho Falls, ID.
Market Cap
$22.7M
View Company Details
INTERNATIONAL ISOTOPES INC by TradingView
Relevant filing section
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. 


On July 12, 2023, Steve T. Laflin gave notice that he is stepping down as Chief Executive Officer of the Company, effective as of September 1, 2023 at the end of the term of his employment agreement. We thank Mr. Laflin for his over 22 years of service as Chief Executive Officer of the Company. Mr. Laflin will continue to serve as a member of the Company's Board of Directors (the "Board") and will also continue to consult for the Company on an ongoing basis.


In addition, on July 12, 2023, Shahe Bagderjian, President of the Company, was appointed to replace Mr. Laflin as Chief Executive Officer, effective September 1, 2023. Mr. Bagderjian's compensation as Chief Executive Officer will be as set forth in his previously disclosed employment agreement with the Company. For additional information regarding Mr. Bagderjian, including the compensation arrangements and other information required by this Item 5.02, see the Company's Current Report on Form 8-K, filed with the Securities and Exchange Commission on May 10, 2023, which is incorporated by reference.


On July 12, 2023, the Board, pursuant to the Restated Certificate of Formation of the Company and the Bylaws of the Company, approved an increase of the size of the Board from three directors to four directors, and appointed Shahe Bagderjian to serve as a director on the Board, effectively immediately. Mr. Bagderjian will not serve on any Board committees and will not receive separate compensation for his service on the Board. There are no understandings or arrangements with any person pursuant to which Mr. Bagderjian was selected as a director, and Mr. Bagderjian is not party to any related party transaction required to be reported pursuant to Item 404(a) of Regulation S-K.